Pharmaceutical group ยท Spain
Almirall
A group of 9 companies with 209 medicines in 7 countries.
Group structure
9 companies in 3 countries
Loading your pageโฆ
Loading your pageโฆ
Pharmaceutical group ยท Spain
A group of 9 companies with 209 medicines in 7 countries.
9 companies in 3 countries
One free account for the Prognia apps: Ward to study, Osler for clinical answers with their sources, and the network to find your colleagues.
Groups are put together by Prognia from the names regulators publish and from company links; they are not an official corporate structure.
Every medicine of every company in the group, current ones first.
1โ25 of 209
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| ACTIKERALLSoluzione cutanea | Salicylic acid, Fluorouracil | Italy | Authorised | |
| ACTIKERALL 5 MG/G + 100 MG/G SOLUCION CUTANEA0,5000 g + 10,0000 g ยท Soluciรณn cutรกnea | Fluorouracil, Salicylic acid | Spain | Marketed | 2013 |
| ACTITHIOL MUCOLITICO ANTIHISTAMรNICO SOLUCIรN ORAL2 g + 0,05 g ยท Soluciรณn oral | Carbocisteine, Promethazine | Spain | Marketed | 1968 |
| ACZONE5% | 7.5% ยท GEL | Dapsone | United States | Marketed | 2005 |
| AIRTALCompressa rivestita | Aceclofenac | Italy | Authorised | |
| AIRTAL 100 mg COMPRIMIDOS RECUBIERTOS CON PELICULA100 mg ยท Comprimido recubierto con pelรญcula | Aceclofenac | Spain | Marketed | 1991 |
| AIRTAL 100 mg POLVO PARA SUSPENSION ORAL100 mg ยท Polvo para suspensiรณn oral | Aceclofenac | Spain | Marketed | 1995 |
| AIRTAL DIFUCREM 15 mg/g CREMA1,50 g ยท Crema | Aceclofenac | Spain | Marketed | 1993 |
| ALMAX 1g/7,5 ml SUSPENSION ORAL13,30 g ยท Suspensiรณn oral | Almagato | Spain | Marketed | 1981 |
| ALMAX 500 mg COMPRIMIDOS MASTICABLES500 mg ยท Comprimido masticable | Almagato | Spain | Marketed | 1981 |
| ALMAX FORTE 1,5 g SUSPENSION ORAL1500 mg ยท Suspensiรณn oral | Almagato | Spain | Marketed | 1989 |
| ALMAX FORTE 750 MG COMPRIMIDOS MASTICABLES750 mg ยท Comprimido masticable | Almagato | Spain | Marketed | 2023 |
| ALMAX FORTE 750 MG COMPRIMIDOS MASTICABLES SABOR COLA750 mg ยท Comprimido masticable | Almagato | Spain | Marketed | 2023 |
| ALMAX FORTE 750 MG COMPRIMIDOS MASTICABLES SABOR FRESA750 mg ยท Comprimido masticable | Almagato | Spain | Marketed | 2023 |
| ALMOGRANCompressa rivestita con film | Almotriptan | Italy | Authorised | |
| ALMOGRAN 12,5 MG COMPRIMIDOS RECUBIERTOS CON PELICULA12,5 mg ยท Comprimido recubierto con pelรญcula | Almotriptan | Spain | Marketed | 2016 |
| ALMOGRAN 12,5 mg COMPRIMIDOS RECUBIERTOS CON PELICULA12,5 mg ยท Comprimido recubierto con pelรญcula | Almotriptan | Spain | Marketed | 1999 |
| ALMOGRAN 12,5 MG COMPRIMIDOS RECUBIERTOS CON PELICULA12,5 mg ยท Comprimido recubierto con pelรญcula | Almotriptan | Spain | Marketed | 2019 |
| ALMOGRAN 12,5 mg COMPRIMIDOS RECUBIERTOS CON PELICULA12,5 mg ยท Comprimido recubierto con pelรญcula | Almotriptan | Spain | Authorised | 2026 |
| ALMOGRAN 12,5 mg COMPRIMIDOS RECUBIERTOS CON PELICULA12,5 mg ยท Comprimido recubierto con pelรญcula | Almotriptan | Spain | Marketed | 2020 |
| ALMOGRAN 12,5 MG COMPRIMIDOS RECUBIERTOS CON PELICULA12,5 mg ยท Comprimido recubierto con pelรญcula | Almotriptan | Spain | Marketed | 2025 |
| ALMOGRAN 12,5 MG COMPRIMIDOS RECUBIERTOS CON PELICULA12,5 mg ยท Comprimido recubierto con pelรญcula | Almotriptan | Spain | Marketed | 2018 |
| ALMOGRAN 12,5 mg COMPRIMIDOS RECUBIERTOS CON PELICULA12,5 mg ยท Comprimido recubierto con pelรญcula | Almotriptan | Spain | Authorised | 2026 |
| ALMOGRAN 12,5 MG COMPRIMIDOS RECUBIERTOS CON PELICULA12,5 mg ยท Comprimido recubierto con pelรญcula | Almotriptan | Spain | Authorised | 2025 |
| Almogran 12,5 mg, filmomhulde tabletFilmomhulde tablet | Almotriptan | Netherlands | Authorised | 2001 |
Where it holds or makes medicines, with how many are current.
| Country | Medicines | Current | Past | Companies |
|---|---|---|---|---|
| Spain | 132 | 119 | 13 | CompaniesAll medicines |
| Netherlands | 25 | 25 | 0 | CompaniesAll medicines |
| Italy | 19 | 19 | 0 | CompaniesAll medicines |
| Saudi Arabia | 15 | 15 | 0 | CompaniesAll medicines |
| United States | 11 | 11 | 0 | CompaniesAll medicines |
| European Union (EMA) | 6 | 6 | 0 | CompaniesAll medicines |
| Romania | 1 | 0 | 1 | CompaniesAll medicines |
Also in the registers of France, Singapore, United Kingdom
The ATC groups most of its medicines belong to, largest first.
The active substances in most of its medicines.
How the registers spell it, normalised: legal forms, accents and capitals removed.
Compiled by Prognia from the public medicine and company registers below. Logos are not used.
Companies are grouped by Prognia from the names regulators publish; not an official corporate structure.
Source: European Medicines Agency (EPAR data).
Licence: EMA reuse policy (source acknowledgement required)
Fuente de la informaciรณn: AEMPS (CIMA).
Licence: AEMPS open data reuse with attribution
Source: U.S. FDA, Drugs@FDA / openFDA. FDA does not endorse this site.
Licence: Public domain (U.S. Government work)
Source: BDPM (ANSM, HAS, UNCAM).
Licence: Licence Ouverte v1.0
Fuente de la informaciรณn: Agencia Espaรฑola de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA presentaciones, acquired 11 October 2026 UTC; each source response/update date retained.
Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required
Fuente de la informaciรณn: Agencia Espaรฑola de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA medicamentos, acquired 11 October 2026 UTC; each source response/update date retained.
Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required
BDPM / ANSM, HAS and UNCAM; original URLs and each update date retained
Licence: BDPM exact Licence Ouverte v1.0 (October 2011)
Medicines and Healthcare products Regulatory Agency (MHRA), GOV.UK; Category 1 list; publication updated 25 August 2026; acquired 2026-10-15T08:18:47.757811+00:00; original workbook cells and factual authorization/holder projections adapted under Open Government Licence v3.0.
Licence: Open Government Licence v3.0; exact Crown copyright 2026 publication grant
Medicines and Healthcare products Regulatory Agency (MHRA), GOV.UK; Category 2 list; publication updated 25 August 2026; acquired 2026-10-15T08:18:48.423930+00:00; original workbook cells and factual authorization/holder projections adapted under Open Government Licence v3.0.
Licence: Open Government Licence v3.0; exact Crown copyright 2026 publication grant
Agenzia Italiana del Farmaco (AIFA); https://www.aifa.gov.it/documents/20142/3815901/Classe_A_per_principio_attivo_31-05-2026.csv; HTTP Last-Modified Mon, 28 Sep 2026 08:46:41 GMT; acquired 2026-10-13T17:21:06.055244+00:00; native fields retained, source identifier and role projections are adaptations.
Licence: CC BY 4.0; AIFA published open-data catalog
Agenzia Italiana del Farmaco (AIFA); https://www.aifa.gov.it/documents/20142/3815901/Classe_H_per_principio_attivo_31-05-2026.csv; HTTP Last-Modified Mon, 28 Sep 2026 08:46:40 GMT; acquired 2026-10-13T17:21:06.034935+00:00; native fields retained, source identifier and role projections are adaptations.
Licence: CC BY 4.0; AIFA published open-data catalog
Agenzia Italiana del Farmaco (AIFA); https://drive.aifa.gov.it/farmaci/confezioni_fornitura.csv; HTTP Last-Modified Mon, 12 Oct 2026 23:02:44 GMT; acquired 2026-10-13T17:21:16.224007+00:00; native fields retained, source identifier and role projections are adaptations.
Licence: CC BY 4.0; AIFA published open-data catalog
College ter Beoordeling van Geneesmiddelen, Geneesmiddeleninformatiebank metadata, source update 07-10-2026; downloaded 08-10-2026; factual adaptation.
Licence: Conditional noncreative administrative factual metadata; no dataset-wide CC0 claim
Ministerul Sฤnฤtฤศii, Catalogul public naลฃional al preลฃurilor, 18 iunie 2021, downloaded 2026-10-08 from data.gov.ro; CC BY 4.0; structured factual adaptation, code whitespace trimmed only where explicitly recorded.
Licence: Creative Commons Attribution 4.0 International (CC BY 4.0)
Saudi Food and Drug Authority (SFDA), foreign human medicine open-data listing, source scope 2023, retrieved 11 October 2026 UTC; exact original file and response modification date retained.
Licence: Exact SFDA open-data section explicitly offers freely usable named human medicine workbooks; factual-data scope only
Contains information from HSA Listing of Registered Therapeutic Products accessed on 8 October 2026 from data.gov.sg, under Singapore Open Data Licence 1.0: https://data.gov.sg/open-data-licence
Licence: Singapore Open Data Licence
Report an error or request removalCorrections from the company itself are welcome.
Well-known pharmaceutical groups, each with all its companies.
Ranked by their number of medicines.